from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0635/hadA

LFCtreatmentdescriptionclass of inhibitor

1.537

Amikacinug/mL Amikacintranslation

1.995

Cap5-10ug/mL Capreomycintranslation

2.267

Rox10-50 ug/mL Roxithromycintranslation

1.009

SM2-5 ug/mL Streptomycintranslation

2.297

Tet5-10 ug/mL Tetracyclinetranslation

0.373

Rif0.2-5ug/mL Rifampicintranscription

0.257

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.545

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.353

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.912

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.013

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.088

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.415

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.509

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.046

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.180

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.050

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.451

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.083

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.350

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.120

KCN5-20 ug/mL Potassium cyaniderespiration

-0.631

NaN30.2-2 mM Sodium aziderespiration

0.669

Nigericin50 uM Nigericinrespiration

-0.980

TRC10-150 ug/mL Triclosanrespiration

-1.893

TRZ10-25 ug/mL Thioridazinerespiration

0.055

Valinomycin0.5-10 uM Valinomycinrespiration

0.524

ZnSO42 mM ZnSO4respiration

-0.097

menadione6-10 ug/mL Menadionerespiration

-0.072

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.468

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.153

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.377

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.266

NRP_1Non-replicating persistence stage 1dosRassociated

0.451

Amp0.2mg/mL AmpicillincellWall

0.048

Cephalexin20-100 ug/mL CephalexincellWall

0.543

Cerulenin0.32-5 ug/mL CerulenincellWall

0.806

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.347

EMB10-20 ug/mL EthambutolcellWall

0.168

Eta12-40 ug/mL EthionamidecellWall

0.324

INH0.2-0.4 ug/mL IsoniazidcellWall

0.521

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.369

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.160

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.285

BZA0.12 mg/mL BenzamidearomaticAmides

-0.174

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.031

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.187

H2O24 mM hydrogen peroxideDNAdamaging

0.677

Levo10 ug/mL LevofloxacinDNAdamaging

0.754

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.618

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.863

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.891

UVUV-irradiationDNAdamaging

-1.033

ARP41-4 ug/mL Antitubercular compound ARP4?

0.538

Antimycin12.5-50 ug/mL Antimycin A?

0.323

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.425

PA_110-50 ug/mL Antitubercular compound PA-1?

0.402

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.817

PA8240.2-2 ug/mL PA-824?

-0.956

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.021

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.216

Verapamil50 uM Verapamil?

-0.155

mercaptoethanol2 mM 2-Mercaptoethanol?

0.623

methoxatin10-20 ug/mL Methoxatin?